Type 2 & other diabetes

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

DiabetologiaPublished Randomised controlled trial

Primary result · Change in HbA1c from baselineResult — go to the resultDifference −0.84 mmol/mol 95% CI −2.99 to 1.31

Authors' conclusion

A commercial behavioural weight management programme combined with remote dietary counselling after diagnosis of type 2 diabetes did not improve HbA1c up to 12 months post intervention in this trial. The intervention could help people achieve weight loss and be cost-effective compared with current standard National Health Service care.

Study context

Population
Adults (≥18 years) with overweight or obesity (BMI≥25 kg/m²) and T2D diagnosed ≤3 years, from 159 primary care practices in England398 completed 12 months
Participants
577 adults
Comparison
Tailored diabetes education and behavioural weight management (DEW) vs standard care diabetes education (DE)
  • DEWn = 289
  • DEn = 288reference
Primary endpoint
Change from baseline in HbA1c
Follow-up
Up to 12 months
Methodological detailspragmatic, parallel two-group, 1:1 allocation stratified by gender and diabetes duration, unblinded participants
  • Pragmatic
  • Parallel two-group
  • 1:1 allocation stratified by gender and diabetes duration
  • Unblinded participants

Primary result

Change in HbA1c from baseline

Difference

−0.84 mmol/mol

95% CI −2.99 to 1.31

P = 0.44

DEWvs DE
difference −0.84 mmol/mol (95% CI −2.99 to 1.31); P = 0.44

As reported in the abstract

Further findings

Change in HbA1c from baseline · 6 months

No evidence of an intervention effect on HbA1c change: difference
−1.83 [−4.05, 0.40] mmol/mol (95% CI)

Weight · 6 months

Intervention effect on weight
−1.77 [−2.86, −0.67] kg (95% CI)

Weight · up to 12 months

Intervention effect on weight
−1.38 [−2.56, −0.19] kg (95% CI)

Cost-effectiveness

DEW cost-effective vs DE in within-trial and lifetime analyses; lifetime incremental cost-effectiveness ratio
£2290 per quality-adjusted life year gained

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes. Diabetologia. Published 23 January 2025. doi:10.1007/s00125-024-06355-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.